• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国非瓣膜性心房颤动患者抗凝治疗依从性的相关因素

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation.

作者信息

Song Ting, Xin Xiao, Cui Peirong, Zong Mingcan, Li Xianhua

机构信息

School of Nursing, Shanghai Jiaotong University, Shanghai, People's Republic of China.

Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

出版信息

Patient Prefer Adherence. 2021 Mar 1;15:493-500. doi: 10.2147/PPA.S285020. eCollection 2021.

DOI:10.2147/PPA.S285020
PMID:33688171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7935330/
Abstract

PURPOSE

Inadequate medication adherence among patients with non-valvular atrial fibrillation (NVAF) will directly affect the efficacy and safety of anticoagulation therapy, leading to a considerable increase in the risk of ischemic stroke and death. In this study, we aim to investigate medication adherence and identify the influencing factors, including social-demographic, disease-related information and self-efficacy.

PATIENTS AND METHODS

We recruited 170 patients with NVAF from a tertiary hospital atrial fibrillation outpatient clinics and cardiology ward from June 2020 to September 2020. Patients who had been taking oral anticoagulation medication for at least 3 months were included. And Morisky medication adherence scale (MGL) was used to assess the adherence to anticoagulants, which scores <4 were considered as low adherence.

RESULTS

Fifty (29.4%) NVAF patients had a MGL score<4. Monthly income, types of comorbidities, number of drugs, and self-efficacy were determinants of anticoagulation adherence. Binomial logistic regression showed that patients had been prescribed more durgs (OR: 3.51, p=0.002), had high monthly income (OR: 7.87, p=0.001), without other diseases (OR: 8.00, p=0.005), and with higher self-efficacy (OR: 1.42, p=0.001) showed high adherence.

CONCLUSION

Number of drugs, types of comorbidities, monthly income, and self-efficacy were associated with the adherence of non-vitamin K antagonist oral anticoagulants (NOACs).

摘要

目的

非瓣膜性心房颤动(NVAF)患者抗凝治疗依从性不佳将直接影响抗凝治疗的疗效和安全性,导致缺血性卒中风险和死亡风险显著增加。在本研究中,我们旨在调查药物治疗依从性并确定影响因素,包括社会人口统计学、疾病相关信息和自我效能感。

患者与方法

我们于2020年6月至2020年9月从一家三级医院的心房颤动门诊和心内科病房招募了170例NVAF患者。纳入至少服用口服抗凝药物3个月的患者。采用Morisky药物治疗依从性量表(MGL)评估抗凝药物依从性,得分<4分被视为低依从性。

结果

50例(29.4%)NVAF患者的MGL得分<4分。月收入、合并症类型、药物数量和自我效能感是抗凝治疗依从性的决定因素。二项逻辑回归显示,服用更多药物(比值比:3.51,p = 0.002)、月收入高(比值比:7.87,p = 0.001)、无其他疾病(比值比:8.00,p = 0.005)以及自我效能感较高(比值比:1.42,p = 0.001)的患者依从性较高。

结论

药物数量、合并症类型、月收入和自我效能感与非维生素K拮抗剂口服抗凝药(NOACs)的依从性相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd13/7935330/13f949c4577b/PPA-15-493-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd13/7935330/13f949c4577b/PPA-15-493-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd13/7935330/13f949c4577b/PPA-15-493-g0001.jpg

相似文献

1
Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation.中国非瓣膜性心房颤动患者抗凝治疗依从性的相关因素
Patient Prefer Adherence. 2021 Mar 1;15:493-500. doi: 10.2147/PPA.S285020. eCollection 2021.
2
Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.心房颤动患者口服抗凝治疗的依从性。聚焦于非维生素K拮抗剂口服抗凝药。
Thromb Haemost. 2017 Jan 26;117(2):209-218. doi: 10.1160/TH16-10-0757. Epub 2016 Nov 10.
3
Recurrent ischemic stroke in atrial fibrillation with non-vitamin K antagonist oral anticoagulation.非维生素K拮抗剂口服抗凝治疗心房颤动时的复发性缺血性卒中
J Clin Neurosci. 2019 Jun;64:127-133. doi: 10.1016/j.jocn.2019.03.037. Epub 2019 Mar 28.
4
Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study.非维生素 K 拮抗剂口服抗凝剂(NOACs)在非瓣膜性心房颤动患者中每日一次或两次给药的安全性:NOAC-TR 研究。
Bosn J Basic Med Sci. 2018 May 20;18(2):185-190. doi: 10.17305/bjbms.2017.2279.
5
Analysis of Influencing Factors of Compliance with Non-Vitamin K Antagonist Oral Anticoagulant in Patients with Nonvalvular Atrial Fibrillation and Correlation with the Severity of Ischemic Stroke.非瓣膜性心房颤动患者非维生素K拮抗剂口服抗凝药依从性的影响因素分析及其与缺血性卒中严重程度的相关性
Evid Based Complement Alternat Med. 2021 Oct 19;2021:1021127. doi: 10.1155/2021/1021127. eCollection 2021.
6
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.依诺肝素、达比加群和阿哌沙班预防新发、未经治疗的非瓣膜性心房颤动卒中和体循环栓塞的依从性。
J Manag Care Spec Pharm. 2016 Nov;22(11):1319-1329. doi: 10.18553/jmcp.2016.22.11.1319.
7
Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.中国江苏省非瓣膜性心房颤动患者口服抗凝治疗的现状及影响因素:一项多中心、横断面研究。
BMC Cardiovasc Disord. 2020 Jan 16;20(1):22. doi: 10.1186/s12872-020-01330-6.
8
Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.非维生素K拮抗剂类口服抗凝药与华法林在非瓣膜性心房颤动患者中的疗效持久性及转归
J Clin Nurs. 2019 May;28(9-10):1839-1846. doi: 10.1111/jocn.14797. Epub 2019 Feb 12.
9
[Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review].[非瓣膜性心房颤动患者对非维生素K拮抗剂口服抗凝药的药物依从性——文献综述]
Vnitr Lek. 2017 Fall;63(10):633-639.
10
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.房颤患者的抗凝依从性及其相关因素:一项横断面研究。
BMJ Open. 2019 Sep 3;9(9):e029974. doi: 10.1136/bmjopen-2019-029974.

引用本文的文献

1
Warfarin Adherence and Its Associated Factors in Thai Older Adults with Atrial Fibrillation.泰国老年房颤患者的华法林依从性及其相关因素
J Multidiscip Healthc. 2024 Sep 14;17:4455-4464. doi: 10.2147/JMDH.S472597. eCollection 2024.
2
Developing and Validating a Self-Care Self-Efficacy Scale for Oral Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Protocol for a Mixed Methods Study.开发和验证非瓣膜性心房颤动患者口服抗凝治疗自我护理自我效能量表的混合方法研究方案。
JMIR Res Protoc. 2024 Sep 13;13:e51489. doi: 10.2196/51489.
3
Knowledge, Adherence, and Satisfaction With Warfarin Therapy and Associated Factors Among Outpatients at University Teaching Hospital in Ethiopia.

本文引用的文献

1
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.房颤患者的抗凝依从性及其相关因素:一项横断面研究。
BMJ Open. 2019 Sep 3;9(9):e029974. doi: 10.1136/bmjopen-2019-029974.
2
Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.直接口服抗凝剂治疗的心房颤动患者药物依从性与疾病认知的相关性:一项观察性横断面初步研究。
PLoS One. 2018 Sep 28;13(9):e0204814. doi: 10.1371/journal.pone.0204814. eCollection 2018.
3
Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.
在埃塞俄比亚的大学教学医院,门诊患者对华法林治疗的知识、依从性和满意度及其相关因素。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241260736. doi: 10.1177/10760296241260736.
老年非瓣膜性心房颤动患者自我报告的直接口服抗凝剂依从性的预测因素。
J Thromb Thrombolysis. 2018 Aug;46(2):139-144. doi: 10.1007/s11239-018-1679-1.
4
Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants.使用新型口服抗凝剂的心房颤动患者中,药物依从性对缺血性中风、大出血和深静脉血栓形成风险的影响。
Curr Med Res Opin. 2018 Jul;34(7):1285-1292. doi: 10.1080/03007995.2018.1428543. Epub 2018 Feb 15.
5
Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.基于远程监测的反馈可改善房颤患者对抗凝药物(非维生素 K 拮抗剂)的依从性。
Eur Heart J. 2018 Apr 21;39(16):1394-1403. doi: 10.1093/eurheartj/ehx762.
6
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.心房颤动患者使用直接口服抗凝剂的依从性及治疗结果:退伍军人健康管理局的研究发现
BMC Cardiovasc Disord. 2017 Sep 2;17(1):236. doi: 10.1186/s12872-017-0671-6.
7
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial.用于房颤管理的移动健康技术:整合决策支持、教育与患者参与——mAF应用试验
Am J Med. 2017 Dec;130(12):1388-1396.e6. doi: 10.1016/j.amjmed.2017.07.003. Epub 2017 Aug 26.
8
Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.真实世界中成人房颤患者直接口服抗凝药物的依从性和持久性。
Pharmacotherapy. 2017 Oct;37(10):1221-1230. doi: 10.1002/phar.1989. Epub 2017 Sep 6.
9
Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR.土耳其非瓣膜性心房颤动患者服用非维生素K拮抗剂口服抗凝药的药物依从性:NOAC-TR研究
Clin Appl Thromb Hemost. 2018 Apr;24(3):525-531. doi: 10.1177/1076029617693940. Epub 2017 Feb 19.
10
Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China.影响中国心房颤动患者对华法林依从性的用药知识和信念的因素。
Patient Prefer Adherence. 2017 Feb 9;11:213-220. doi: 10.2147/PPA.S120962. eCollection 2017.